Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel fatty acid synthase inhibitors designed

Aug. 7, 2012

New bacterial strain targets hypoxic regions of solid tumors

Aug. 7, 2012

U.S. university and Novartis form global alliance for anticancer T-cell immunotherapies

Aug. 6, 2012

FDA assigns PDUFA action date for enzalutamide NDA

Aug. 6, 2012

Zaltrap approved in U.S. for cancer indication

Aug. 6, 2012

GSK confirms submissions for dabrafenib and trametinib

Aug. 6, 2012

Beta Pharma patents novel protein kinase inhibitors

Aug. 6, 2012

MEK inhibitor improves survival in METRIC trial

Aug. 6, 2012

Pol I inhibitor shows anticancer potency in vitro and in vivo

Aug. 6, 2012

Sirolimus reduces skin cancer occurrence in renal transplant recipients

Aug. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...